290 related articles for article (PubMed ID: 10445369)
1. Corticotropin-releasing factor antagonist attenuates the "anxiogenic-like" effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats.
Basso AM; Spina M; Rivier J; Vale W; Koob GF
Psychopharmacology (Berl); 1999 Jul; 145(1):21-30. PubMed ID: 10445369
[TBL] [Abstract][Full Text] [Related]
2. Antagonism of corticotropin-releasing factor attenuates the enhanced responsiveness to stress observed during protracted ethanol abstinence.
Valdez GR; Zorrilla EP; Roberts AJ; Koob GF
Alcohol; 2003 Feb; 29(2):55-60. PubMed ID: 12782246
[TBL] [Abstract][Full Text] [Related]
3. Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats.
Rodríguez de Fonseca F; Rubio P; Menzaghi F; Merlo-Pich E; Rivier J; Koob GF; Navarro M
J Pharmacol Exp Ther; 1996 Jan; 276(1):56-64. PubMed ID: 8558457
[TBL] [Abstract][Full Text] [Related]
4. Effect of corticotropin-releasing factor antagonist on behavioral and neuroendocrine responses during exposure to defensive burying paradigm in rats.
Korte SM; Korte-Bouws GA; Bohus B; Koob GF
Physiol Behav; 1994 Jul; 56(1):115-20. PubMed ID: 8084889
[TBL] [Abstract][Full Text] [Related]
5. Antagonism of cannabinoid 1 receptors reverses the anxiety-like behavior induced by central injections of corticotropin-releasing factor and cocaine withdrawal.
Kupferschmidt DA; Newman AE; Boonstra R; Erb S
Neuroscience; 2012 Mar; 204():125-33. PubMed ID: 21784132
[TBL] [Abstract][Full Text] [Related]
6. Conditioned increases in anxiogenic-like behavior following exposure to contextual stimuli associated with cocaine are mediated by corticotropin-releasing factor.
DeVries AC; Pert A
Psychopharmacology (Berl); 1998 Jun; 137(4):333-40. PubMed ID: 9676892
[TBL] [Abstract][Full Text] [Related]
7. Brain corticotropin-releasing factor mediates 'anxiety-like' behavior induced by cocaine withdrawal in rats.
Sarnyai Z; Bíró E; Gardi J; Vecsernyés M; Julesz J; Telegdy G
Brain Res; 1995 Mar; 675(1-2):89-97. PubMed ID: 7796157
[TBL] [Abstract][Full Text] [Related]
8. Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor.
Valdez GR; Roberts AJ; Chan K; Davis H; Brennan M; Zorrilla EP; Koob GF
Alcohol Clin Exp Res; 2002 Oct; 26(10):1494-501. PubMed ID: 12394282
[TBL] [Abstract][Full Text] [Related]
9. Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal.
Rassnick S; Heinrichs SC; Britton KT; Koob GF
Brain Res; 1993 Mar; 605(1):25-32. PubMed ID: 8467387
[TBL] [Abstract][Full Text] [Related]
10. CRF antagonist reverses the "anxiogenic" response to ethanol withdrawal in the rat.
Baldwin HA; Rassnick S; Rivier J; Koob GF; Britton KT
Psychopharmacology (Berl); 1991; 103(2):227-32. PubMed ID: 2027923
[TBL] [Abstract][Full Text] [Related]
11. Time-dependent induction of anxiogenic-like effects after central infusion of urocortin or corticotropin-releasing factor in the rat.
Spina MG; Merlo-Pich E; Akwa Y; Balducci C; Basso AM; Zorrilla EP; Britton KT; Rivier J; Vale WW; Koob GF
Psychopharmacology (Berl); 2002 Mar; 160(2):113-21. PubMed ID: 11875628
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptide Y blocks anxiogenic-like behavioral action of corticotropin-releasing factor in an operant conflict test and elevated plus maze.
Britton KT; Akwa Y; Spina MG; Koob GF
Peptides; 2000 Jan; 21(1):37-44. PubMed ID: 10704717
[TBL] [Abstract][Full Text] [Related]
13. Functional antagonism between nociceptin/orphanin FQ and corticotropin-releasing factor in rat anxiety-related behaviors: involvement of the serotonergic system.
Filaferro M; Ruggieri V; Novi C; Calò G; Cifani C; Micioni Di Bonaventura MV; Sandrini M; Vitale G
Neuropeptides; 2014 Aug; 48(4):189-97. PubMed ID: 24894718
[TBL] [Abstract][Full Text] [Related]
14. A study of the lasting effects of cocaine pre-exposure on anxiety-like behaviors under baseline conditions and in response to central injections of corticotropin-releasing factor.
Erb S; Kayyali H; Romero K
Pharmacol Biochem Behav; 2006 Sep; 85(1):206-13. PubMed ID: 16987545
[TBL] [Abstract][Full Text] [Related]
15. Corticotropin-releasing factor receptor blockade enhances conditioned aversive properties of cocaine in rats.
Heinrichs SC; Klaassen A; Koob GF; Schulteis G; Ahmed S; De Souza EB
Psychopharmacology (Berl); 1998 Apr; 136(3):247-55. PubMed ID: 9566810
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a novel and potent corticotropin-releasing factor antagonist in rats.
Menzaghi F; Howard RL; Heinrichs SC; Vale W; Rivier J; Koob GF
J Pharmacol Exp Ther; 1994 May; 269(2):564-72. PubMed ID: 8182523
[TBL] [Abstract][Full Text] [Related]
17. Alpha-helical CRF(9-41) prevents anxiogenic-like effect of NPY Y1 receptor antagonist BIBP3226 in rats.
Kask A; Rägo L; Harro J
Neuroreport; 1997 Nov; 8(16):3645-7. PubMed ID: 9427342
[TBL] [Abstract][Full Text] [Related]
18. Corticotropin-releasing factor and defensive withdrawal: inhibition of monoamine oxidase prevents habituation to chronic stress.
Ward HE; Johnson EA; Goodman IJ; Birkle DL; Cottrell DJ; Azzaro AJ
Pharmacol Biochem Behav; 1998 May; 60(1):209-15. PubMed ID: 9610944
[TBL] [Abstract][Full Text] [Related]
19. Corticotropin releasing factor antagonist, alpha-helical CRF(9-41), reverses nicotine-induced conditioned, but not unconditioned, anxiety.
Tucci S; Cheeta S; Seth P; File SE
Psychopharmacology (Berl); 2003 May; 167(3):251-6. PubMed ID: 12669178
[TBL] [Abstract][Full Text] [Related]
20. Corticotropin-releasing factor receptor type 1 mediates stress-induced relapse to cocaine-conditioned place preference in rats.
Lu L; Liu D; Ceng X
Eur J Pharmacol; 2001 Mar; 415(2-3):203-8. PubMed ID: 11275000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
